RxDoctor Payments Data

David Walt, MD

Family Medicine · Cleveland, MSNPI 1205895448

Payments from drug & device makers

$2,151in general payments, 2019–2025

Across 148 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$340
  • Mylan Specialty L.p.$273
  • GSK$252
  • AstraZeneca$225
  • Sunovion Pharmaceuticals Inc.$217
  • Pfizer$166
  • plus $678 from 18 others

What the payments were for

  • Food & beverage$2,151100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,151 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$94,662
Medicare patients
327
Services billed
2,750

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban171$111,655
JardianceEmpagliflozin76$74,179
JanuviaSitagliptin Phosphate60$52,760
XareltoRivaroxaban45$40,007
FarxigaDapagliflozin Propanediol33$36,792
LinzessLinaclotide30$30,381
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,696
Novolog FlexpenInsulin Aspart15$5,448
Potassium Chloride284$5,131
Breo ElliptaFluticasone/Vilanterol12$4,700
Albuterol Sulfate HfaAlbuterol Sulfate105$3,844
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,785
Gabapentin272$3,528
Fiasp FlextouchInsulin Aspart (Niacinamide)11$3,245
Atorvastatin Calcium404$3,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$166$111,655171 claims
Boehringer IngelheimJardiance$35$74,17976 claims
Johnson & JohnsonXarelto$11$40,00745 claims
AstraZenecaFarxiga$225$36,79233 claims
GSKTrelegy Ellipta, Breo Ellipta$252$15,39529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Cleveland

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →